首页> 美国卫生研究院文献>BMC Research Notes >Modified response evaluation criteria in solid tumors is superior to response evaluation criteria in solid tumors for assessment of responses to sorafenib in patients with advanced hepatocellular carcinoma

【2h】

Modified response evaluation criteria in solid tumors is superior to response evaluation criteria in solid tumors for assessment of responses to sorafenib in patients with advanced hepatocellular carcinoma

机译：在晚期肝细胞癌患者中改良的实体瘤反应评估标准优于实体瘤反应评估标准以评估索拉非尼的反应

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundModified response evaluation criteria in solid tumors (mRECIST) and RECIST are used to assess the effect of treatment with targeted agents for hepatocellular carcinoma (HCC). The aim of this study was to determine which set of criteria is superior in patients with advanced HCC treated with sorafenib.

机译：背景实体瘤中的改良反应评估标准（mRECIST）和RECIST用于评估靶向药物治疗肝细胞癌（HCC）的效果。这项研究的目的是确定在索拉非尼治疗的晚期HCC患者中哪套标准更好。

著录项

期刊名称 BMC Research Notes
作者
Juichi Takada; Hisashi Hidaka; Takahide Nakazawa; Masaaki Kondo; Kazushi Numata; Katsuaki Tanaka; Kotaro Matsunaga; Chiaki Okuse; Satoshi Kobayashi; Manabu Morimoto; Shinichi Ohkawa; Wasaburo Koizumi;
展开▼
作者单位

展开▼
年(卷),期 2015(8),-1
年度 2015
页码 609
总页数 10
原文格式 PDF
正文语种
中图分类
关键词
Hepatocellular carcinoma Sorafenib RECIST Modified RECIST;

机译：肝细胞癌;索拉非尼;RECIST;改良的RECIST;

相似文献

外文文献
中文文献
专利

1. Alternative response criteria (Choi, European association for the study of the liver, and modified Response Evaluation Criteria In Solid Tumors [RECIST]) versus RECIST 1.1 in patients with advanced hepatocellular carcinoma treated with sorafenib [J] . RonotM., BouattourM., WassermannJ., The oncologist . 2014,第4期

机译：索拉非尼治疗的晚期肝细胞癌患者的替代反应标准（Choi，欧洲肝脏研究协会，以及改良的实体瘤反应评估标准[RECIST]）与RECIST 1.1
2. Alternative Response Criteria (Choi, European Association for the Study of the Liver, and Modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib [J] . Maxime Ronot, Mohamed Bouattour, Johanna Wassermann, The oncologist . 2014,第4期

机译：替代响应标准（CHOI，欧洲肝脏研究协会，以及固体肿瘤的修饰响应评估标准[RECIST]）与索拉非尼治疗晚期肝细胞癌患者的再读数1.1
3. CT imaging findings in patients with advanced hepatocellular carcinoma treated with sorafenib: Alternative response criteria (Choi, European Association for the Study of the Liver, and modified Response Evaluation Criteria in Solid Tumor (mRECIST)) versus RECIST 1.1 [J] . Gavanier M., Ayav A., Sellal C., European Journal of Radiology . 2016,第1期

机译：索拉非尼治疗的晚期肝细胞癌患者的CT影像学表现：替代反应标准（Choi，欧洲肝病研究协会，以及改良的实体瘤反应评估标准（mRECIST））与RECIST 1.1
4. Photoacoustic-ultrasonic imaging biomarkers for treatment-response assessment of sorafenib in a rat model of hepatocellular carcinoma [C] . Houra Taghavi, Nina Munoz, Mohamed Naser, IEEE International Ultrasonics Symposium . 2017

机译：光声-超声成像生物标记物用于索拉非尼在肝细胞癌大鼠模型中的治疗反应评估
5. Comparison of linear, bi-dimensional and volumetric measurements in evaluating tumor response of Hepatocellular carcinoma lesions in the arterial and portal venous phases on MRI. [D] . Pratt, Michelle Sherman. 2015

机译：在MRI上评估动脉，门静脉期肝细胞癌病变的线性，二维和体积测量结果的比较。
6. Alternative Response Criteria (Choi European Association for the Study of the Liver and Modified Response Evaluation Criteria in Solid Tumors RECIST) Versus RECIST 1.1 in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib [O] . Maxime Ronot, Mohamed Bouattour, Johanna Wassermann, 2014

机译：索拉非尼治疗晚期肝细胞癌患者的替代反应标准（Choi欧洲肝病研究协会和改良的实体瘤反应评估标准RECIST）与RECIST 1.1的比较
7. Modified response evaluation criteria in solid tumors is superior to response evaluation criteria in solid tumors for assessment of responses to sorafenib in patients with advanced hepatocellular carcinoma [O] . 2015

机译：在晚期肝细胞癌患者中，改良的实体瘤反应评估标准优于实体瘤反应评估标准，以评估索拉非尼的反应

Modified response evaluation criteria in solid tumors is superior to response evaluation criteria in solid tumors for assessment of responses to sorafenib in patients with advanced hepatocellular carcinoma

摘要

著录项

相似文献

相关主题

期刊订阅